Stem Cells of Adult Organisms in Biology and Medicine

Open access

Summary

The life span of adult cells is restricted, becoming senescent and eventually undergoing apoptosis. Cells are replaced by new ones which originate from a population of stem cells. An example is provided by the hemopoietic system in the bone marrow. In an adult body, stem cells may be identified by markers present in both embryonic and tissue-specific stem cells. Oct3/4, CXCR4, Nanog, CD133 and CD34 are examples of such markers. The stem cells share several properties, such as they may: 1) replicate and give rise to new stem cells, 2) differentiate into heterogenous tissue and organ specific cells and, finally, 3) stem cells are self-protected against various toxic agents and radiation. In adult tissues, stem cells reside in specialized sites (niches), for example in the bone marrow, skin, digestive tract epithelium, and skeletal muscles. Stem cells residing in these stem cell niches are anchored there by chemokines and adhesion molecules. Stroma-Derived Factor-1 (SDF-1), α-chemokine and stem-cell expressed receptor CXCR4 play an important role in the retention of stem cells in such niches. Several stress factors may attenuate the SDF-1-CXCR4 axis in the bone marrow, which leads to the release of stem cells from their niches into circulation. Another important stem cell niche-anchoring mechanism is the interaction of Wnt (a ligand) with Frizzled LRP (receptor). The recently accumulated evidence suggests that malignancy arises from an arrest in maturation and mutation of stem cells. Cancer stem cells are responsible for tumor growth, its relapse and metastasis. The first direct evidence for the existence of cancer stem cells came from observations of acute myeloblastic leukemia. Currently, cell populations enriched for cancer stem cells have been isolated from several tumors. The cancer stem cells represent less than 1% of tumor cells in the mouse models.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] AASEN T RAYA A BARRARO MJ et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nature Biotechnol 2008; 26: 1276-1284.

  • [2] ALBERTS B BRAY D HOPKIN K et al. Essential Cell Biology 2005 PWN.

  • [3] AL-HAJJ M CLARKE MF. Self-renewal and solid tumor stem cells. Oncogene 2004; 23: 7274-7282.

  • [4] ALLAN DS KEENEY M HOWSON-JAN K et al. Number of viable CD34+ cells reinfused predicts engrafment in autologous hemopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 967-972.

  • [5] BARKER N van ES JH KUIPERS J et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.

  • [6] BLAUPLAIN C LOWRY WE GEOGHEGAN A et al. Self-renewal multipotency and the existence of two cell populations within an epithelial stem cell niche. Cell 2004;118: 635-648.

  • [7] BRAMBRINK T FOREMAN R WELSTEAD GG et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008; 2: 151-159.

  • [8] CADIGAN KM NUSSE R. Wnt signaling: a common theme in animal development. Genes Dev 1997; 11: 3286-3305.

  • [9] CHENG JH SHE H HAN Y-P et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest 2008; 294: G39-G49.

  • [10] CIEMERYCH MA. Embryonic stem cells - searching for the pluripotency. Post Biol Komorki 2008; 35: 183-205.

  • [11] COLLINS AT BERRY PA HYDE C et al. Prospective identification of tumorogenic prostate cancer stem cells. Cancer Res 2005; 65: 10946-10951.

  • [12] [DALERBA P DYLLA SJ PARK IK et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci US 2007; 104: 10158-10163.

  • [13] DELORME B RINGE J PONTIKOGLOU C et al. Specific lineage-priming of bone marrow mesenchymal stem cells provides the molecular framework for their plasticity. Stem Cells 2009; 27: 1142-1151.

  • [14] FANG D NGUYEN TK LEISHEAR K et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005; 65: 9328-9337.

  • [15] FEURING-BUSKE M [10] HOGGE DE. Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38- progenitor cells from patients with acute myeloid leukemia. Blood 2001; 97: 3882-3889.

  • [16] FLOMENBERG N DEVINE SM DIPERSIO JF et al. The use of AMD3100 plus G-CSF for autologous hemopoietic progenitor cell mobilization is superior to G-CSF alone. Blood 2005; 106: 1867-1874.

  • [17] FURNE JK SPRINGFIELD JR HO SB LEVITT MD. Simplification of the end-alveolar carbon monoxide technique to assess erythrocyte survival. J Lab Clin Med 2003; 142: 52-57.

  • [18] GIBBS CP KUKEKOV VG REITH JD et al. Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 2005; 7: 967-976.

  • [19] GLANGRECO A GROOT KR JANES SM. Lung cancer and lung stem cells. Strange bedfellows? Am J Respir Crit Care Med 2007; 175: 547-553.

  • [20] HANNA J MARKONLAKI S SCHOERDRET P et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 2008; 133: 250-261.

  • [21] HAYASHI O KATSUBE Y HIROSE M et al. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow periosteum and adipose tissue. Calcif Tissue Int 2008; 82: 238-247.

  • [22] HESS DA BONDE J CRAFT TC et al. Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by G-CSF. Biol Blood Marrow Transpl 2007; 13: 398-411.

  • [23] HIRSCHMANN-JAX C FOSTER AE WULF GG et al. A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci US 2004; 101: 14228-14233.

  • [24] HOPE KJ JIN L DICK JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nature Immunol 2004; 5: 738-743.

  • [25] JEDRZEJCZAK WW. Proposition of polish nomenclature in experimental hematology. in Ultrastructure and function of cell ed. Kawiak J Osuchowska Z Przełęcka A vol.3 PWN Warsaw 1989.

  • [26] JOANNIDES A GAUGHWIN P SCHWIENING C et al. Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells. Lancet 2004; 364: 172-178.

  • [27] JORDAN CT GUZMAN ML NOBLE M. Cancer stem cells. N Engl J Med. 2006; 355: 1253-1261.

  • [28] KAWALEC M SKORSKI T KAWIAK J. Successful chemoimmunotherapy of murine L1210 lymphatic leukemia with cyclophosphamide and mafosfamide-treated leukemia cells. Invest New Drugs 1988; 6: 169-172.

  • [29] KENNEDY LJ Jr WEISSMAN IL. Dual origin of intimal cells in cardiac-allograft arteriosclerosis. New Engl J Med 1971; 285: 884-887.

  • [30] KIM JB ZAEHRES H WU G et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 2008; 454: 646-650.

  • [31] KONDO T SETOGUCHI T TAGA T. Persistence of small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci US 2004; 101: 781-786.

  • [32] KUCIA M HALASA M WYSOCZYNSKI M et al. Morphological and molecular characterization of novel population of CXCR4+SSEA-4+Oct-4+ very small embryonic-like cells purified from human cord blood - preliminary report. Leukemia 2007; 21: 297-303.

  • [33] KUCIA M RECA R CAMPBELL FR et al. A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow. Leukemia 2006; 20: 857-869.

  • [34] LAPIDOT T SIRARD C VORMOOR J et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 1994; 367: 645-648.

  • [35] LEVESQUE JP HENDY J TAKARNATSU Y et al. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by G-CSF or cyclofosfamide. J Clin Invest 2003; 111: 187-196.

  • [36] LILES WC RODGER E BROXMEYER HE et al. Augumented mobilization and collection of CD34+ hemopoietic cells from normal human volunteers stimulated with G-CSF by single-dose administration of AMD3100 a CXCR4 antagonist. Transfusion 2005; 45: 295-300.

  • [37] LOGAN CY NUSSE R. The Wnt signaling pathway in development and disease. Ann Rev Cell Dev Biol 2004; 20: 781-810.

  • [38] LOH YH AGRAVAL S PARK IH et al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113: 5476-5479.

  • [39] LOU H DEAN M. Targeted therapy for cancer stem cells: the patched pathway and ABC transporters. Oncogene 2007; 26: 1357-1360.

  • [40] MEISSNER A WERING M JAENISCH R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nature Biotechnol 2007; 25: 1177-1181.

  • [41] MEYER KC KLATTE JE DINH HV et al. Evidence that the bulge region is a site of relative immune privilege in human hair follicles. Br J Dermatol 2008; 159: 1077-1085.

  • [42] NOWACKA-ZAWISZA M KRAJEWSKA WM. The role of BCRA1 BCRA2 and RAD51 proteins in the maintenance of genome stability. Post Biol Komorki 2009; 36: 679-694.

  • [43] O’BRIEN CA POLLET A GALLINGER S DICK JE. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007; 445: 106-110.

  • [44] O’CONNOR MD KARDEL MD IOSFINA I et al. Alkaline phosphatase-positive colony formation is a sensitive specific and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 2008; 26: 1109-1116.

  • [45] OHYAMA M. Advances in the study of stem cell-enriched hair follicle bulge cells: a review featuring characterization and isolation of human bulge cells. Dermatology 2007; 214: 342-351.

  • [46] OKITA K ICHISAKA T YAMANAKA S. Generation of germline-competent induced pluripotent stem cells. Nature 2007; 448: 313-317.

  • [47] PATRAWALA L CALHOUN T SCHNEIDER-BROUSSARD R et al. Highly purified CD44 prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696-1708.

  • [48] PATTHEY C EDLUND T GUNHAGA L. Wnt-regulated temporal control of BMP exposure directs the choice between neural plate border and epidermal fate. Development 2009; 136: 73-83.

  • [49] RATAJCZAK MZ ZUBA-SURMA EK MACHALINSKI B et al. Very small embryonic-like (VSEL) stem cells: purification from adult organs characterization and biological significance. Stem Cell Rev 2008; 4: 89-99.

  • [50] REYA T CLEVERS H. Wnt signalling in stem cells and cancer. Nature 2005; 434: 843-850.

  • [51] RICCI-VITIANI L LOMBARDI DG PILOZZI E et al. Identification and expression of human coloncancer- initiating cells. Nature 2007; 445: 111-115.

  • [52] ROBEY RW STEADMAN K POLGAR O et al. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res 2004; 64: 1242-1246.

  • [53] ROBEY RW TO KK POLGAR O et al. ABCG2: a perspective. Adv Drug Deliv Rev 2009; 61: 3-13.

  • [54] ROSSANT J. Stem cells and early lineage development. Cell 2008; 132: 527-531.

  • [55] SHI Q RAFII S HONG-DEWU M et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.

  • [56] SILVA J BARRANDON O NICHOLS J et al. (2008) Promotion of reprogramming to ground state pluripotency by signal inhibition. PLoS Biol 6: e253.

  • [57] SINGH SK HAWKINS C CLARKE ID et al. Identification of human brain tumor initiating cells. Nature 2004; 432: 396-401

  • [58] SWERTS K DEMOLERLOOSE B DHOOGE C et al. Prognostic significance of multidrug resistance-related proteins in childhood acute lymphoblastic leukemia. Eur J Cancer 2006; 42: 295-309.

  • [59] TALENS-VISCONTI R BONORA A JOVER R et al. Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal cells. World J Gastroenterol 2006; 12: 5834-5845.

  • [60] TANG C ANG BT PERVAIZ S. Cancer stem cell: target for anti-cancer therapy. FASEB J 2007; 21: 3777-3785.

  • [61] THOMSON JA ITZKOVITZ-ELDOR J SHAPIRO SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147.

  • [62] VINDIGNI V MICHELOTTO L LANCEROTTO L et al. Isolation method for a stem cell population with neural potential from skin and adipose tissue. Neurol Res 2009; publ ahad PMID15246730

  • [63] WOJAKOWSKI W TENDERA M MICHALOWSKA A et al. Mobilization of CD34/CXCR4+ CD34/CD117+ c-met+ stem cells and mononuclear cells expressing early cardiac muscle and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation 2004; 110: 3213-3220.

  • [64] WRIGHT DE WAGERS AJ GULATI AP et al. Physiological migration of hemopoietic stem and progenitor cells. Science 2001; 294: 1933-1936.

  • [65] WYSOCZYNSKI M RECA R RATAJCZAK J et al. Incorporation of CXCR4 into membrane lipid rafts primes doming-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005; 105: 40-48.

  • [66] YILMAZ OH VALDEZ R THEISEN BK et al. Pten dependence distinguishes hemopoietic stem cells from leukemia-initiating cells. Nature 2006; 441: 475-482

  • [67] ZUBA-SURMA EK KUCIA M ABDEL-LATIF A et al. Morphological characterization of very small embryonic-like stem cells (VSELs) by ImageStream system analysis. J Cell Mol Med 2008; 12: 292-303.

  • [68] ZUBA-SURMA EK WU W RATAJCZAK J et al. Very small embryonic-like stem cells in adult tissues - potential implications for aging. Mech Ageing Dev 2009; 130: 58-66.

Search
Journal information
Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 256 140 6
PDF Downloads 85 54 1